Insights

Growing Gene Therapy Market PROGEN specializes in innovative AAV analytical tools and viral titer assays, positioning it to capitalize on the expanding demand for gene therapy development across academia, biotech, and pharmaceutical industries.

Product Innovation & Launches Recent launches of advanced AAV assays and viral quantification kits highlight opportunities to cross-sell complementary analytical and reagent products to existing and new biotech customers developing gene therapy vectors.

Strategic Acquisitions The acquisition of EuroProxima's research antibody line and recent partnership with Thermo Fisher open avenues to offer a broader portfolio of high-quality antibodies and research tools, attracting customers seeking integrated solutions.

Corporate Expansion & Acquisition Yuhan's recent $23M investment in PROGEN suggests increased access to resources and potential growth, enabling a proactive approach to expanding sales efforts within European and global markets for life sciences research.

Niche Market Focus With a focus on specialized tools for gene therapy and life sciences research, PROGEN offers sales opportunities targeting high-growth segments such as gene editing, vector manufacturing, and therapeutic development, especially among biotech startups and research institutions.

PROGEN Tech Stack

PROGEN uses 8 technology products and services including Hotjar, Open Graph, Amazon Simple Email Service, and more. Explore PROGEN's tech stack below.

  • Hotjar
    Analytics
  • Open Graph
    Content Management System
  • Amazon Simple Email Service
    Email
  • Prototype
    Javascript Frameworks
  • reCAPTCHA
    Security
  • Google Tag Manager
    Tag Management
  • FedEx
    Transportation And Fleet Management
  • CivicTheme
    UI Frameworks

Media & News

PROGEN's Email Address Formats

PROGEN uses at least 2 format(s):
PROGEN Email FormatsExamplePercentage
First.Last@progen.deJohn.Doe@progen.de
100%
First.Last@progen.comJohn.Doe@progen.com
100%

Frequently Asked Questions

What is PROGEN's phone number?

Minus sign iconPlus sign icon
You can contact PROGEN's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is PROGEN's stock symbol?

Minus sign iconPlus sign icon
PROGEN is a publicly traded company; the company's stock symbol is PROGEN.ST.

What is PROGEN's official website and social media links?

Minus sign iconPlus sign icon
PROGEN's official website is progen.com and has social profiles on LinkedIn.

What is PROGEN's SIC code NAICS code?

Minus sign iconPlus sign icon
PROGEN's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does PROGEN have currently?

Minus sign iconPlus sign icon
As of December 2025, PROGEN has approximately 46 employees across 6 continents, including South AmericaEuropeAsia. Key team members include Chief Executive Officer: K. B.Ceo: M. L.General Manager: S. K.. Explore PROGEN's employee directory with LeadIQ.

What industry does PROGEN belong to?

Minus sign iconPlus sign icon
PROGEN operates in the Biotechnology Research industry.

What technology does PROGEN use?

Minus sign iconPlus sign icon
PROGEN's tech stack includes HotjarOpen GraphAmazon Simple Email ServicePrototypereCAPTCHAGoogle Tag ManagerFedExCivicTheme.

What is PROGEN's email format?

Minus sign iconPlus sign icon
PROGEN's email format typically follows the pattern of First.Last@progen.de. Find more PROGEN email formats with LeadIQ.

When was PROGEN founded?

Minus sign iconPlus sign icon
PROGEN was founded in 1983.

PROGEN

Biotechnology ResearchBaden-württemberg, Germany11-50 Employees

By delivering robust and reliable viral and non-viral gene therapy tools, antibodies, proteins, and kits to scientists worldwide, we empower researchers in academia, biotech, and pharmaceutical industries and commercial manufacturers to advance scientific discovery and develop breakthrough therapies.

Founded in 1983, PROGEN is one of Germany's first biotech companies. We collaborate with gene therapy experts worldwide to design innovative solutions that help scientists overcome research, analytical, and manufacturing challenges.

Beyond supplying products, we partner with our customers to understand their unique needs and provide specialized support throughout their research journey.

PROGEN specializes in: 

- Advanced AAV analytical research tools and standard reagents
- Highly sensitive and widely published AAV ELISA kits
- Premium antibodies optimized for gene therapy applications 
- Lipid nanoparticle (LNP) delivery kits
- Specialized antibodies and proteins for life sciences research

Our commitment extends beyond product manufacturing. We strive to advance life-changing therapies by providing our customers with reliable, consistent, and high-quality tools that meet the exact demands of modern gene therapy development.

Visit www.progen.com to explore our comprehensive catalog of advanced tools!

Making gene therapy better. Together.

Imprint: https://bit.ly/3uEZf2h

Section iconCompany Overview

Phone number
Website
progen.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PROGEN.ST
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1983
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    PROGEN's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    PROGEN's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.